glp-1

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing the following…

3 weeks ago

HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms

New Offerings Bring Millions Affordable Healthcare Solutions During Open Enrollment Season October 14, 2025 08:00 ET  | Source: HealthEquity, Inc.…

2 months ago

Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform

Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost adherence, retention and deliver breakthrough health outcomes with…

4 months ago

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited

License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra™ (resmetirom)…

4 months ago

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

Bowling Green, July 03, 2025 (GLOBE NEWSWIRE) -- Section 1 – Introduction In 2025, the discourse surrounding prescription weight loss…

5 months ago